Roche: positive phase III data in lymphoma

Roche: Lunsumio approved in lymphoma in the USA

Roche: Approval in lymphoma in Canada

Roche: approval in lymphoma in Canada

Roche: sBLA accepted by the FDA in lymphoma

Novartis: FDA approval in lymphoma